Alveolar soft part sarcoma in childhood: Is Sunitinib-Sutent® treatment an effective approach?

Pediatric Blood and Cancer

Volumn 58, Issue 3, 2012, Pages 475-476

  Hilbert, Marjorie ^a   Mary, Pierre ^b   Larroquet, Michelle ^b   Serinet, Marie Odile ^a   Helfre, Sylvie ^a   Brisse, Herve ^a   Coulomb, Aurore ^b   Orbach, Daniel ^a  

^a INSTITUT CURIE   (France)

^b ARMAND TROUSSEAU HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; DACTINOMYCIN; DOXORUBICIN; IFOSFAMIDE; SUNITINIB; TRABECTEDIN; VINCRISTINE;

ADOLESCENT; ALVEOLAR SOFT PART SARCOMA; CASE REPORT; CHILD; CLINICAL FEATURE; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HUMAN; LETTER; LUNG METASTASIS; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; SCHOOL CHILD; SYMPTOM; TREATMENT OUTCOME;

ADOLESCENT; ANGIOGENESIS INHIBITORS; CHILD; COMBINED MODALITY THERAPY; FEMALE; HUMANS; INDOLES; LUNG NEOPLASMS; PYRROLES; RECEPTOR PROTEIN-TYROSINE KINASES; SARCOMA, ALVEOLAR SOFT PART;

EID: 84855813808     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.23303     Document Type: Letter

References (8)

1. Casanova M, Ferrari A, Bisogno G, et al. Alveolar soft part sarcoma in children and adolescents: A report from the Soft-Tissue Sarcoma Italian Cooperative Group. Ann Oncol 2000; 11: 1445-1449.
2. Pennacchioli E, Fiore M, Collini P, et al. Alveolar soft part sarcoma: Clinical presentation, treatment, and outcome in a series of 33 patients at a single institution. Ann Surg Oncol 2010; 17(12): 3229-3233.
3. Stacchiotti S, Negri T, Zaffaroni N, et al. Sunitinib in advanced alveolar soft part sarcoma: Evidence of a direct antitumor effect. Ann Oncol 2011; 17: 1682-1690.
4. Ghose A, Tariq Z, Veltri S. Treatment of multidrug resistant advanced alveolar soft part sarcoma with sunitinib. Am J Ther 2010; 10. (Epub ahead of print).
5. Williams A, Bartle G, Sumathi VP, et al. Detection of ASPL/TFE3 fusion transcripts and the TFE3 antigen in formalin-fixed, paraffin-embedded tissue in a series of 18 cases of alveolar soft part sarcoma: Useful diagnostic tools in cases with unusual histological features. Virchows 2011; 458(3): 291-300. Epub 2011 Jan 2029.
6. Malouf GG, Camparo P, Oudard S, et al. Targeted agents in metastatic Xp11 translocation/TFE3 gene fusion renal cell carcinoma (RCC): A report from the Juvenile RCC Network. Ann Oncol 1834; 21(9): 1834-1838.
7. Janeway KA, Albritton KH, Van Den Abbeele AD, et al. Sunitinib treatment in pediatric patients with advanced GIST following failure of imatinib. Pediatr Blood Cancer 2009; 52(7): 767-771.
8. Dubois SG, Shusterman S, Ingle AM, et al. Phase I and pharmacokinetic study of sunitinib in pediatric patients with refractory solid tumors: A Children's Oncology Group Study. Clin Cancer Res 2011; 20: 1-10.